Philips and B. Braun receive FDA clearance for breakthrough Onvision needle tip tracking technology for regional anesthesia

Auction Alert - Premier Medical Depot - Closing Dec 2nd - Bid on Over 365 Lots

Philips and B. Braun receive FDA clearance for breakthrough Onvision needle tip tracking technology for regional anesthesia

Press releases may be edited for formatting or style | August 25, 2020 Ultrasound

"Onvision is the groundbreaking technology that allows anesthesiologists the predictability [4] and confidence [4] they need while positioning the needle during a procedure," said Dr. Angela Karpf, M.D., Corporate Vice President of Medical Affairs at B. Braun. "B. Braun continues to add products to our regional anesthesia therapy portfolio that help achieve faster postsurgical recoveries, optimize procedural workflow and enhance user experience."

Together, B. Braun's Stimuplex Onvision needles and Philips' Onvision needle tip tracking technology indicate the position of the needle tip in relation to the ultrasound viewing plane to an accuracy of 3mm [3]. A sensitive micro-sensor placed on the needle, combined with advanced signal processing and visualization techniques on the Xperius system, indicate the real-time location of the needle tip in relation to the 2D ultrasound viewing plane. The solution provides greater flexibility in needle trajectory [8] and can reduce procedure times [4].

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs

In addition to FDA clearance, the Onvision solution is CE marked. It is available for sale across the EU and in Chile and is expected to be available in the United States in Q4 2020.

Onvision needle is manufactured by B Braun and the Onvision module for Xperius is manufactured by Philips. Onvision is a registered trademark of B. Braun and Philips. Stimuplex is a registered trademark of B. Braun Medical Inc.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap and CAPS.

You Must Be Logged In To Post A Comment